Literature DB >> 20593932

Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.

Suzana Shahar1, Rabeta Mohd Salleh, Ahmad Rohi Ghazali, Poh Bee Koon, Wan Nazaimoon Wan Mohamud.   

Abstract

BACKGROUND: Lack of physical activities throughout life is related to obesity and is a risk factor of breast cancer, however, the associations of these factors with adiponectin in the occurrence of breast cancer have not been well investigated.
OBJECTIVE: This study investigated the relationship between adiposity, lifetime physical activities and serum adiponectin as breast cancer risk factors among Malaysian women in Klang Valley, Malaysia.
DESIGN: A case-control study was carried out among 70 newly diagnosed breast cancer patients and 138 controls aged 29 to 65 years old in Klang Valley.
SUBJECTS: The inclusion criteria for both groups were not having menstruation for premenopausal women, no evidence of pregnancy, not lactating and no chronic diseases such as hypertension and diabetes at the time of data collection. In addition, the cases must be pathologically newly diagnosed with breast cancer (stage I to III) and not on any therapy for cancer, with the exception of surgery. The controls were matched with cases for age +/- 5 years and menopausal status. MEASUREMENTS: Subjects were interviewed to obtain information on socio-demography, health and reproductive history using a pretested questionnaire. Subjects were also asked on their engagement of physical activity since secondary school. Anthropometric parameters included height, weight, waist and hips were also measured. A total of 6 ml of fasting venous blood was drawn for analysis of serum adiponectin in duplicate using Linko Adiponectin ELISA Kit. Fasting blood glucose (FBG) and blood pressure were also measured.
RESULTS: Mean body mass index (BMI) among cases and controls were not significantly different (p> 0.05) at 26.1 -/+ 4.8 kg/m2 and 25.3 -/+ 4.5 kg/m2, respectively. FBG among cases (6.3 -/+ 1.8 mmol/L) was higher than controls (5.6 -/+ 1.1 mmol/L) (p<0.05). Waist hip ratio (WHR) of cases (0.85 -/+ 0.07) was also higher than controls (0.80 -/+ 0.06) (p<0.05). Abdominal obesity (WHR > 0.85) increased risk of breast cancer by three folds [Adjusted OR 3.3 (95%CI 1.8-6.2)] (p<0.05). Adiponectin level was inversely related to waist circumference (r=-0.510, p=0.000), BMI (r=-0.448, p=0.000) and FBG (r=-0.290, p=0.026). Adiponectin level in cases (11.9 -/+ 4.8 microg/ml) were lower than controls (15.2 -/+ 7.3 microg/ml) (p<0.05). A greater reduction of breast cancer risk was observed with the increasing level of serum adiponectin level according to percentiles (p<0.05). Subjects with mean serum adiponectin level at the highest quintile (> 75th)( >or= 16.7 microg/ml) had 80% reduced risk of breast cancer [Adjusted OR 0.2 (0.0-0.6)](p<0.05). A higher percentage of cases (47%) had not engaged in any physical activity throughout life as compared to controls (19%)[Adjusted OR 3.7 (1.7-7.7)](p<0.001).
CONCLUSIONS: Abdominal obesity and physical inactivity throughout life were associated with low serum adiponectin and breast cancer risk among subjects. Thus, it is essential for Malaysian women to be physically active and achieve a healthy waistline in order to increase serum adiponectin level and reduce breast cancer risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593932

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  13 in total

1.  Commentary: towards a definite coherent heterogeneity in meta-analyses.

Authors:  Jeanine M Genkinger; Mary Beth Terry
Journal:  Int J Epidemiol       Date:  2014-07-04       Impact factor: 7.196

Review 2.  Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.

Authors:  Debora Macis; Aliana Guerrieri-Gonzaga; Sara Gandini
Journal:  Int J Epidemiol       Date:  2014-04-15       Impact factor: 7.196

3.  ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.

Authors:  Seung J Chung; Ganji Purnachandra Nagaraju; Arumugam Nagalingam; Nethaji Muniraj; Panjamurthy Kuppusamy; Alyssa Walker; Juhyung Woo; Balázs Győrffy; Ed Gabrielson; Neeraj K Saxena; Dipali Sharma
Journal:  Autophagy       Date:  2017-07-11       Impact factor: 16.016

Review 4.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

Review 5.  Insights into the Link Between Obesity and Cancer.

Authors:  Sarah E Ackerman; Olivia A Blackburn; François Marchildon; Paul Cohen
Journal:  Curr Obes Rep       Date:  2017-06

6.  Risk and protective factors for breast cancer in Midwest of Brazil.

Authors:  Lívia Emi Inumaru; Maíra Irineu Gomes Duarte Quintanilha; Érika Aparecida da Silveira; Maria Margareth Veloso Naves
Journal:  J Environ Public Health       Date:  2012-05-15

7.  The role of adiponectin in breast cancer: a meta-analysis.

Authors:  Li-Yuan Liu; Meng Wang; Zhong-Bing Ma; Li-Xiang Yu; Qiang Zhang; De-Zong Gao; Fei Wang; Zhi-Gang Yu
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

Review 8.  Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies.

Authors:  Tai Wei; Peng Ye; Xin Peng; Li-Ling Wu; Guang-Yan Yu
Journal:  Oncotarget       Date:  2016-07-26

9.  A case-control study on risk factors of breast cancer in Han Chinese women.

Authors:  Li-Yuan Liu; Fei Wang; Shu-De Cui; Fu-Guo Tian; Zhi-Min Fan; Cui-Zhi Geng; Xu-Chen Cao; Zhen-Lin Yang; Xiang Wang; Hong Liang; Shu Wang; Hong-Chuan Jiang; Xue-Ning Duan; Hai-Bo Wang; Guo-Lou Li; Qi-Tang Wang; Jian-Guo Zhang; Feng Jin; Jin-Hai Tang; Liang Li; Shi-Guang Zhu; Wen-Shu Zuo; Li-Xiang Yu; Yu-Juan Xiang; Fei Zhou; Liang Li; Qiang Zhang; Qin-Ye Fu; Zhong-Bing Ma; De-Zong Gao; Yu-Yang Li; Lu Liu; Chun-Miao Ye; Yong-Jiu Wang; Wen-Zhong Zhou; Zhi-Gang Yu
Journal:  Oncotarget       Date:  2017-10-09

10.  Serum adiponectin level and different kinds of cancer: a review of recent evidence.

Authors:  Vajihe Izadi; Elaheh Farabad; Leila Azadbakht
Journal:  ISRN Oncol       Date:  2012-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.